# A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects

> **NCT02955420** · PHASE1 · COMPLETED · sponsor: **Berlin Cures GmbH** · enrollment: 74 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BC 007
- **DRUG:** NaCl 0.9 %

## Key facts

- **NCT ID:** NCT02955420
- **Lead sponsor:** Berlin Cures GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2018-04
- **Final completion:** 2018-05
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02955420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02955420, "A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02955420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*